National Healthcare Properties (NHP) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
6 Aug, 2026Executive summary
Completed a successful IPO in April 2026, raising $531.3 million and issuing 44.3 million shares, with proceeds used to repay debt and fund acquisitions.
Achieved substantial execution on strategic objectives, including SHOP portfolio growth, capital concentration in senior housing, and balance sheet strengthening.
Closed or placed under contract approximately $400 million of senior housing since Q2 start, with highly accretive yields and 19 acquisitions completed.
Advanced transition to a full SHOP portfolio, with significant divestitures of outpatient medical facilities (OMF) and non-core assets.
Strengthened governance with new board appointments, including Albert M. Campbell, and ongoing refreshment.
Financial highlights
Second quarter normalized FFO was $10.9 million, or $0.18 per share; Nareit FFO was $0.19 per share; net loss attributable to common stockholders was $(0.13) per share.
SHOP segment same-store cash NOI grew 20.1% year-over-year, driven by occupancy, rate, and margin improvements; OMF segment same-store cash NOI declined 0.4%.
Same-store average occupancy reached 84.1%, up 140 basis points from Q2 2025.
Same-store RevPOR increased 5.9% year-over-year to $6,390.
Consolidated NOI increased to $33.4 million from $31.2 million year-over-year.
Outlook and guidance
Increased SHOP same-store cash NOI growth guidance to 15%-18% for the year, or $51.6M-$52.9M.
OMF same-store cash NOI growth guidance unchanged at 2.5%-3.5%, or $81.2M-$82M.
Acquisition guidance for 2026 remains $375M-$425M; disposition guidance increased to $570M.
G&A and equity compensation guidance raised by $1M each due to board refreshment; full-year G&A now $27-$28M, equity-based compensation $6-$7M.
Recurring CapEx guidance unchanged at $22M-$25M, with spending weighted to the back half of the year.
Latest events from National Healthcare Properties
- Q2 2025 saw robust NOI growth, improved leverage, and $1.8M in preferred stock repurchases.NHP
Q2 20258 Jul 2026 - Q3 2025 NOI rose 12.2%, leverage improved, and net loss narrowed to $15.9M.NHP
Q3 202531 May 2026 - Q2 AFFO rose 13.8% to $4.4M, but a $98.2M fee drove a $119.9M net loss; internalization underway.NHP
Q2 202431 May 2026 - AFFO per share up 5x YoY, leverage improved, and SHOP segment delivered strong NOI growth.NHP
Q1 202531 May 2026 - Normalized FFO per share jumped 163% as senior housing NOI soared and leverage improved.NHP
Q4 202531 May 2026 - AFFO up 26.4% YoY to $1.9M; internalization, dispositions, and reverse split improved efficiency.NHP
Q3 202431 May 2026 - Q4 2024 AFFO soared 576% year-over-year, with leverage and portfolio quality significantly improved.NHP
Q4 202428 May 2026 - Strong NOI growth, higher occupancy, and lower leverage drive robust performance and outlook.NHP
Investor presentation28 May 2026 - All proposals passed, board re-elected, and auditor ratified at the annual meeting.NHP
AGM 202618 May 2026